U.S. Markets open in 9 hrs 28 mins

Flexion Therapeutics soars on FDA label change approval

Flexion Therapeutics shares are soaring, after the FDA approved a label change for Zilretta, a treatment for osteoarthritis knee pain. Yahoo Finance's Anjalee Khemlani joins Seana Smith on The Ticker to discuss.